12 completed, 2 unknown, 1 active not recruiting, 1 withdrawn. 6 Phase 4, 4 Phase 2, 3 Not applicable, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 4, Unknown 2 |
| Phase 2 | 4 | Completed 3, Active not recruiting 1 |
| Not applicable | 3 | Completed 2, Withdrawn 1 |
| Phase 3 | 3 | Completed 3 |
Follow MMR: new trials by email Literature Review of MMR trials Research Report on MMR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Booster Dose of sIPV Co-administered With MMR and HepA-I. sIPV, MMR, HepA-I - Poliomyelitis | Phase 4 | Completed | Sinovac Biotech Co., Ltd | 889 | 2024-08-08 | 2026-01-16 |
| Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) Vero cell-drived inactive Japanese encephalitis vaccine, Measles-Mumps-Rubella Vaccine - Japanese Encephalitis, Measles | Phase 4 | Completed | Liaoning Chengda Biotechnology CO., LTD | 408 | 2024-03-02 | 2025-08-28 |
| Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) SL-BUP, XR-BUP, XR-NTX - Opioid Use Disorder (OUD) | Phase 2 | Active not recruiting | NYU Langone Health | 1516 | 2021-06-08 | 2026-10-01 |
| Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR sIPV+DTaP+MMR, sIPV, DTaP - Vaccine | Phase 4 | Unknown | China National Biotec Group Company Limited | 600 | 2020-11-13 | 2020-12-10 |
| A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts Measles-Mumps-Rubella Vaccine, Vit D - Verruca Viral | Not applicable | Completed | B.P. Koirala Institute of Health Sciences | 66 | 2020-06-01 | 2021-04-09 |
| Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts Measles-Mumps-Rubella Vaccine, cryotherapy - Common Wart, Plantar Wart | Phase 4 | Completed | Assiut University | 48 | 2017-08-01 | 2020-06-16 |
| Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers MenACYW conjugate vaccine, MMR, Varicella - Meningitis, Meningococcal | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1183 | 2016-11-07 | 2022-04-05 |
| Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine Live attenuated SA 14-14-2 Japanese Encephalitis vaccine, Measles, mumps, rubella vaccine - Encephalitis, Japanese, Measles | Phase 4 | Completed | PATH | 628 | 2016-10-13 | 2020-10-14 |
| Homeopathic Vaccine Trial MMR, Tdap, Diphtherinum® - Healthy Volunteers | Phase 4 | Unknown | McMaster University | 2016-09-01 | 2017-08-04 | |
| Calibration of MR and PET-MR Imaging Protocols at RIC PET-MR imaging on Biograph mMR scanner, MR-only imaging on Biograph mMR scanner, MR imaging on the Siemens Vida 3T MR scanner - Cancer, Coronary Artery Disease | Not applicable | Withdrawn | Cedars-Sinai Medical Center | 2014-09-01 | 2024-08-21 | |
| Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old Cervarix, Priorix, Infanrix - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 148 | 2012-10-15 | 2020-04-10 |
| A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months MenACWY-CRM, DTaP-IPV/Hib, HBV - Meningococcal Disease | Phase 3 | Completed | Novartis Vaccines | 529 | 2009-11-01 | 2014-04-21 |
| B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants MenACWY-CRM, DTaP-Hib-IPV, PCV - Meningococcal Disease | Phase 2 | Completed | Novartis Vaccines | 216 | 2007-07-01 | 2014-10-01 |
| Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study rMenB, rMenB+OMV, DTaP-Hib-IPV - Healthy | Phase 2 | Completed | Novartis Vaccines | 147 | 2006-09-01 | 2015-10-09 |
| Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs Pneumococcal 7-valent conjugate vaccine, Pneumococcal polysaccharide vaccine, Hepatitis B vaccine - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 101 | 2006-02-01 | 2021-11-01 |
| Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) MenACWY-CRM, MenC-CRM, DTaP-Hib-IPV - Meningococcal Meningitis | Phase 2 | Completed | Novartis Vaccines | 175 | 2005-06-01 | 2018-10-09 |
Meningococcal Infections (4) · Encephalitis, Japanese (2) · Measles (2) · Meningitis (2) · Meningitis, Meningococcal (2) · Mumps (2) · Rubella (2) · Warts (2) · Coronary Artery Disease (1) · HIV Infections (1) · Neoplasms (1) · Opioid-Related Disorders (1) · Papillomavirus Infections (1) · Poliomyelitis (1)
Novartis Vaccines (4) · Assiut University (1) · B.P. Koirala Institute of Health Sciences (1) · Cedars-Sinai Medical Center (1) · China National Biotec Group Company Limited (1) · GlaxoSmithKline (1) · Liaoning Chengda Biotechnology CO., LTD (1) · McMaster University (1) · NYU Langone Health (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · PATH (1) · Sanofi Pasteur, a Sanofi Company (1) · Sinovac Biotech Co., Ltd (1)
United States (4) · Canada (3) · China (3) · Mexico (2) · United Kingdom (2) · Australia (1) · Colombia (1) · Egypt (1) · Nepal (1) · Panama (1) · Philippines (1) · Puerto Rico (1) · Russia (1) · South Korea (1) · Thailand (1)
Bibisha Baaniya, MBBS (1) · Daniel S. Berman, M.D. (1) · Edward V Nunes, MD (1) · Fenyang Tang (1) · Francisco Diaz-Mitoma, Dr. (1) · Huanyu Wang (1) · John Rotrosen, MD (1) · Maria Rosario Capeding, MD (1) · Mark Abzug, MD (1) · Pan Hongxing (1) · Roger Weiss, MD (1)
PMID 15897380, PMID 15987315, PMID 20202055, PMID 23198256, PMID 23336207, PMID 23566945, PMID 23813361, PMID 23954381, PMID 24934912, PMID 25070525, PMID 26294740, PMID 27730031, PMID 28384048, PMID 28852295, PMID 30003983, PMID 30447324, PMID 30623542, PMID 30775294, PMID 30920098, PMID 33814028, PMID 38657730, PMID 39842691, PMID 40330772, PMID 41276263, PMID 41295459
UG1DA013035 (1), UG1DA015831 (1)